Ronald W Penczek insider trades: Elevance Health (ELV) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronald reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | ELV | ↓ Sell | 369 | $403.16 | $149K | Direct | Jun 15, 2026 (3d) |
| May 19, 2026 | ELV | ↓ Sell | 1,531 | $403.13 | $617K | Direct | May 20, 2026 (1d) |
| Mar 10, 2025 | ELV | ↓ Sell | 443 | $415.13 | $184K | Direct | Mar 11, 2025 (1d) |
| Mar 6, 2024 | ELV | ↓ Sell | 916 | $504.58 | $462K | Direct | Mar 8, 2024 (2d) |
| Nov 30, 2023 | ELV | ↓ Sell | 1,055 | $475.17 | $501K | Direct | Dec 1, 2023 (1d) |
| Oct 24, 2023 | ELV | ↓ Sell | 64 | $454.35 | $29K | Direct | Oct 26, 2023 (2d) |
| Mar 3, 2022 | ANTM | ↓ Sell | 2,423 | $463.68 | $1.1M | Direct | Mar 3, 2022 (0d) |
| Feb 7, 2022 | ANTM | ↓ Sell | 2,763 | $453.48 | $1.3M | Direct | Feb 8, 2022 (1d) |
| Oct 28, 2021 | ANTM | ↓ Sell | 1,150 | $436.00 | $501K | Direct | Oct 29, 2021 (1d) |
| Mar 5, 2021 | ANTM | ↓ Sell | 2,068 | $333.94 | $691K | Direct | Mar 8, 2021 (3d) |
| Mar 4, 2021 | ANTM | ↓ Sell | 67 | $323.56 | $22K | Direct | Mar 5, 2021 (1d) |
| Nov 9, 2020 | ANTM | ↓ Sell | 1,199 | $330.75 | $397K | Direct | Nov 10, 2020 (1d) |
| Jun 8, 2020 | ANTM | ↓ Sell | 545 | $297.74 | $162K | Direct | Jun 10, 2020 (2d) |
| Nov 13, 2019 | ANTM | ↓ Sell | 1,173 | $285.48 | $335K | Direct | Nov 14, 2019 (1d) |
| May 30, 2019 | ANTM | ↓ Sell | 763 | $279.00 | $213K | Direct | May 31, 2019 (1d) |
| Sep 4, 2018 | ANTM | ↓ Sell | 763 | $265.56 | $203K | Direct | Sep 6, 2018 (2d) |
| Mar 7, 2018 | ANTM | ↓ Sell | 1,966 | $231.90 | $456K | Direct | Mar 9, 2018 (2d) |
| Nov 7, 2017 | ANTM | ↓ Sell | 978 | $217.42 | $213K | Direct | Nov 9, 2017 (2d) |
| Jun 7, 2017 | ANTM | ↓ Sell | 867 | $187.46 | $163K | Direct | Jun 8, 2017 (1d) |
| Mar 6, 2017 | ANTM | ↓ Sell | 729 | $165.56 | $121K | Direct | Mar 7, 2017 (1d) |
| Mar 2, 2017 | ANTM | ↓ Sell | 1,213 | $166.56 | $202K | Direct | Mar 3, 2017 (1d) |
| Nov 22, 2016 | ANTM | ↓ Sell | 820 | $138.29 | $113K | Direct | Nov 22, 2016 (0d) |
| Aug 3, 2016 | ANTM | ↓ Sell | 552 | $128.37 | $71K | Direct | Aug 5, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELV insiders
Open-market trades in the last 12 months
About Ronald W Penczek's insider trades
Ronald W Penczek is CAO & Controller at Elevance Health (ELV). Since Aug 3, 2016, Ronald has reported no open-market purchases and 23 sales worth $8.2M on SEC Form 4. In the last 12 months: 2 sales ($766K).
Their filings also include shares withheld for taxes (13 filings), option exercises (12 filings), grants and awards (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.